Cefazolin for Injection 250 mg is a potent first-generation cephalosporin antibiotic formulated as a dry powder intended for reconstitution and administration via intravenous (IV) or intramuscular (IM) routes. It specifically targets susceptible bacterial pathogens by inhibiting their cell wall synthesis, effectively treating a broad spectrum of infections. This product is clinically indicated for respiratory tract infections, skin and soft tissue infections, bone and joint infections, urinary tract infections, and bacterial endocarditis. Its 250 mg dosage offers an optimal concentration for efficacious antimicrobial activity while minimizing the risk of resistance development. Ideal for hospital, clinical, and healthcare use, Cefazolin for Injection 250 mg ensures reliable bacterial eradication when susceptibility is confirmed, facilitating patient recovery from complex infections.
Key Features
| Features | Description |
|---|---|
| Form | Dry powder for injection |
| Strength | 250 mg per vial |
| Route of Administration | Intravenous (IV) or Intramuscular (IM) |
| Antibiotic Class | First-generation cephalosporin |
| Indications | Respiratory tract infections, skin and soft tissue infections, bone and joint infections, urinary tract infections, bacterial endocarditis |
| Mechanism of Action | Inhibits bacterial cell wall synthesis |
| Packaging | Sterile single-dose vial |
| Storage Conditions | Store in a cool, dry place, protect from light |
| Preparation | Requires reconstitution with suitable solvent before administration |
| Attributes | Description |
|---|---|
| Active Ingredient | Cefazolin sodium equivalent to 250 mg cefazolin |
| Physical State | White to off-white sterile powder |
| Reconstitution Solvent | Sterile Water for Injection or suitable diluent |
| pH Range | Approximately 6.5 to 8.5 after reconstitution |
| Shelf Life | Typically 2 years from manufacture date |
| Dosage Form | Injection |
| Vial Size | 10 mL vial or as per packaging |
| Manufacturer Guidance | Administer IV injection slowly over 3-5 minutes or IM as per clinical discretion |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
Yes, Cefazolin for Injection 250 mg is designed for both intravenous (IV) and intramuscular (IM) routes of administration.
It is indicated for respiratory tract infections, skin and soft tissue infections, bone and joint infections, urinary tract infections, and bacterial endocarditis caused by susceptible bacteria.
It must be reconstituted with sterile water for injection or a suitable diluent as per manufacturer guidelines before IV or IM administration.
Yes, Cefazolin Injection 250 mg is appropriate for use in hospitals and clinical settings requiring effective treatment of bacterial infections.
Cefazolin works by inhibiting bacterial cell wall synthesis, leading to bacterial cell death.
Country Of Origin: India
Key Features:
